Loading
Latest filing published 10 Jan 2018 for Immunovaccine Inc., €5,798.
James Willis Hall is a declared insider of Immunovaccine Inc., with filings sourced from SEDI. We count 5 filings; the first trade dates from 8 June 2016 and the latest from 8 January 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 10 January 2018, reports an option exercise of €5,798 in Immunovaccine Inc. The median gap between a trade and its publication by SEDI is 1 day. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations